Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

BACKGROUND: Bipolar disorder is a chronic illness with a 2-year recurrence rate of approximately 50% among individuals receiving treatment in the community. The aim of this 18-month, open-label, continuation study was to evaluate the long-term safety and effectiveness of lurasidone in patients who i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikalov, Andrei, Tsai, Joyce, Mao, Yongcai, Silva, Robert, Cucchiaro, Josephine, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332323/
https://www.ncbi.nlm.nih.gov/pubmed/28168632
http://dx.doi.org/10.1186/s40345-017-0075-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332323/
https://www.ncbi.nlm.nih.gov/pubmed/28168632
http://dx.doi.org/10.1186/s40345-017-0075-7

Ejemplares similares